BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 34033646)

  • 1. Associations between infection intensity categories and morbidity prevalence in school-age children are much stronger for Schistosoma haematobium than for S. mansoni.
    Wiegand RE; Secor WE; Fleming FM; French MD; King CH; Deol AK; Montgomery SP; Evans D; Utzinger J; Vounatsou P; de Vlas SJ
    PLoS Negl Trop Dis; 2021 May; 15(5):e0009444. PubMed ID: 34033646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bladder morbidity and hepatic fibrosis in mixed Schistosoma haematobium and S. mansoni Infections: a population-wide study in Northern Senegal.
    Meurs L; Mbow M; Vereecken K; Menten J; Mboup S; Polman K
    PLoS Negl Trop Dis; 2012; 6(9):e1829. PubMed ID: 23029589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significantly reduced intensity of infection but persistent prevalence of schistosomiasis in a highly endemic region in Mali after repeated treatment.
    Landouré A; Dembélé R; Goita S; Kané M; Tuinsma M; Sacko M; Toubali E; French MD; Keita AD; Fenwick A; Traoré MS; Zhang Y
    PLoS Negl Trop Dis; 2012; 6(7):e1774. PubMed ID: 22860153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protocol and baseline data for a multi-year cohort study of the effects of different mass drug treatment approaches on functional morbidities from schistosomiasis in four African countries.
    Shen Y; King CH; Binder S; Zhang F; Whalen CC; Evan Secor W; Montgomery SP; Mwinzi PNM; Olsen A; Magnussen P; Kinung'hi S; Phillips AE; Nalá R; Ferro J; Aurelio HO; Fleming F; Garba A; Hamidou A; Fenwick A; Campbell CH; Colley DG
    BMC Infect Dis; 2017 Sep; 17(1):652. PubMed ID: 28962552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Praziquantel treatment of school children from single and mixed infection foci of intestinal and urogenital schistosomiasis along the Senegal River Basin: monitoring treatment success and re-infection patterns.
    Webster BL; Diaw OT; Seye MM; Faye DS; Stothard JR; Sousa-Figueiredo JC; Rollinson D
    Acta Trop; 2013 Nov; 128(2):292-302. PubMed ID: 23022016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of single versus mixed Schistosoma haematobium and S. mansoni infections on morbidity profiles amongst school-children in Taveta, Kenya.
    Gouvras AN; Kariuki C; Koukounari A; Norton AJ; Lange CN; Ireri E; Fenwick A; Mkoji GM; Webster JP
    Acta Trop; 2013 Nov; 128(2):309-17. PubMed ID: 23313322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of two closely spaced doses of praziquantel against Schistosoma haematobium and S. mansoni and re-infection patterns in school-aged children in Niger.
    Garba A; Lamine MS; Barkiré N; Djibo A; Sofo B; Gouvras AN; Labbo R; Sebangou H; Webster JP; Fenwick A; Utzinger J
    Acta Trop; 2013 Nov; 128(2):334-44. PubMed ID: 22940014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gender-related differences in prevalence, intensity and associated risk factors of Schistosoma infections in Africa: A systematic review and meta-analysis.
    Ayabina DV; Clark J; Bayley H; Lamberton PHL; Toor J; Hollingsworth TD
    PLoS Negl Trop Dis; 2021 Nov; 15(11):e0009083. PubMed ID: 34788280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Micro-geographical heterogeneity in Schistosoma mansoni and S. haematobium infection and morbidity in a co-endemic community in northern Senegal.
    Meurs L; Mbow M; Boon N; van den Broeck F; Vereecken K; Dièye TN; Abatih E; Huyse T; Mboup S; Polman K
    PLoS Negl Trop Dis; 2013; 7(12):e2608. PubMed ID: 24386499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Schistosomiasis - Assessing Progress toward the 2020 and 2025 Global Goals.
    Deol AK; Fleming FM; Calvo-Urbano B; Walker M; Bucumi V; Gnandou I; Tukahebwa EM; Jemu S; Mwingira UJ; Alkohlani A; Traoré M; Ruberanziza E; Touré S; Basáñez MG; French MD; Webster JP
    N Engl J Med; 2019 Dec; 381(26):2519-2528. PubMed ID: 31881138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urogenital schistosomiasis infection prevalence targets to determine elimination as a public health problem based on microhematuria prevalence in school-age children.
    Wiegand RE; Fleming FM; Straily A; Montgomery SP; de Vlas SJ; Utzinger J; Vounatsou P; Secor WE
    PLoS Negl Trop Dis; 2021 Jun; 15(6):e0009451. PubMed ID: 34115760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The epidemiology of schistosomiasis in Egypt: summary findings in nine governorates.
    El-Khoby T; Galal N; Fenwick A; Barakat R; El-Hawey A; Nooman Z; Habib M; Abdel-Wahab F; Gabr NS; Hammam HM; Hussein MH; Mikhail NN; Cline BL; Strickland GT
    Am J Trop Med Hyg; 2000 Feb; 62(2 Suppl):88-99. PubMed ID: 10813505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and risk factors of schistosomiasis among primary school children in four selected regions of The Gambia.
    Joof E; Sanyang AM; Camara Y; Sey AP; Baldeh I; Jah SL; Ceesay SJ; Sambou SM; Sanyang S; Wade CM; Sanneh B
    PLoS Negl Trop Dis; 2021 May; 15(5):e0009380. PubMed ID: 33974623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Control and Elimination of Schistosomiasis as a Public Health Problem: Thresholds Fail to Differentiate Schistosomiasis Morbidity Prevalence in Children.
    Wiegand RE; Secor WE; Fleming FM; French MD; King CH; Montgomery SP; Evans D; Utzinger J; Vounatsou P; de Vlas SJ
    Open Forum Infect Dis; 2021 Jul; 8(7):ofab179. PubMed ID: 34307724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics of persistent hotspots of Schistosoma mansoni in western Côte d'Ivoire.
    Assaré RK; N'Tamon RN; Bellai LG; Koffi JA; Mathieu TI; Ouattara M; Hürlimann E; Coulibaly JT; Diabaté S; N'Goran EK; Utzinger J
    Parasit Vectors; 2020 Jul; 13(1):337. PubMed ID: 32616074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of single versus mixed schistosome species infections on liver, spleen and bladder morbidity within Malian children pre- and post-praziquantel treatment.
    Koukounari A; Donnelly CA; Sacko M; Keita AD; Landouré A; Dembelé R; Bosqué-Oliva E; Gabrielli AF; Gouvras A; Traoré M; Fenwick A; Webster JP
    BMC Infect Dis; 2010 Jul; 10():227. PubMed ID: 20670408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Schistosoma haematobium infection on urinary tract pathology, nutritional status and anaemia in school-aged children in two different endemic areas of the Niger River Basin, Mali.
    Sacko M; Magnussen P; Keita AD; Traoré MS; Landouré A; Doucouré A; Madsen H; Vennervald BJ
    Acta Trop; 2011 Sep; 120 Suppl 1():S142-50. PubMed ID: 21195046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and efficacy of praziquantel syrup (Epiquantel®) against Schistosoma haematobium and Schistosoma mansoni in preschool-aged children in Niger.
    Garba A; Lamine MS; Djibo A; Tahirou A; Aouami MA; Alfari A; Phillips AE; Fenwick A; Utzinger J
    Acta Trop; 2013 Nov; 128(2):318-25. PubMed ID: 23237719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and risk factors of Schistosoma mansoni infection among preschool-aged children from Panamasso village, Burkina Faso.
    Cisse M; Sangare I; Djibougou AD; Tahita MC; Gnissi S; Bassinga JKW; Konda S; Diallo AH
    Parasit Vectors; 2021 Apr; 14(1):185. PubMed ID: 33794961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Six rounds of annual praziquantel treatment during a national helminth control program significantly reduced schistosome infection and morbidity levels in a cohort of schoolchildren in Zimbabwe.
    Mduluza T; Jones C; Osakunor DNM; Lim R; Kuebel JK; Phiri I; Manangazira P; Tagwireyi P; Mutapi F
    PLoS Negl Trop Dis; 2020 Jun; 14(6):e0008388. PubMed ID: 32569278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.